{"title":"可乐定在治疗更年期症状中的作用。","authors":"O. Ylikorkala","doi":"10.1097/00006254-197605000-00019","DOIUrl":null,"url":null,"abstract":"Twenty-five women suffering from climacteric complaints after surgical castration were treated with clonidine in a placebo controlled trial. Clonidine in the dose of 75 to 150 mug daily diminished the attack rates of flushing and sweating significantly. It can be recommended as a safe therapy for climacteric patients, at least those with contra-indications to oestrogen therapy.","PeriodicalId":75496,"journal":{"name":"Annales chirurgiae et gynaecologiae Fenniae","volume":"64 4 1","pages":"242-5"},"PeriodicalIF":0.0000,"publicationDate":"1976-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00006254-197605000-00019","citationCount":"11","resultStr":"{\"title\":\"Clonidine in the treatment of menopausal symptoms.\",\"authors\":\"O. Ylikorkala\",\"doi\":\"10.1097/00006254-197605000-00019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Twenty-five women suffering from climacteric complaints after surgical castration were treated with clonidine in a placebo controlled trial. Clonidine in the dose of 75 to 150 mug daily diminished the attack rates of flushing and sweating significantly. It can be recommended as a safe therapy for climacteric patients, at least those with contra-indications to oestrogen therapy.\",\"PeriodicalId\":75496,\"journal\":{\"name\":\"Annales chirurgiae et gynaecologiae Fenniae\",\"volume\":\"64 4 1\",\"pages\":\"242-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1976-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/00006254-197605000-00019\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales chirurgiae et gynaecologiae Fenniae\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/00006254-197605000-00019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales chirurgiae et gynaecologiae Fenniae","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/00006254-197605000-00019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clonidine in the treatment of menopausal symptoms.
Twenty-five women suffering from climacteric complaints after surgical castration were treated with clonidine in a placebo controlled trial. Clonidine in the dose of 75 to 150 mug daily diminished the attack rates of flushing and sweating significantly. It can be recommended as a safe therapy for climacteric patients, at least those with contra-indications to oestrogen therapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
